2530
M. A. R. C. Bulusu et al. / Tetrahedron Letters 45 (2004) 2527–2530
Med. Surg. 2001, 20, 233–241; (d) Hebert, A.; Warken,
K. A.; Cherill, R. Semin. Cutaneous Med. Surg. 2001, 20,
260–267; (e) Wellington, K.; Jarvis, B. Drugs 2002, 62,
was prepared from 1 through monosilylation of 33-OH,
EvansÕ reduction of C(22)@O (1.1 equiv Me4Nþ
(OAc)3HBꢀ, CH3CN/AcOH (100:35), )5 to 3 °C, 12 h,
70%), followed by silylation (3.0 equiv (CliPr2Si)2O,
3.0 equiv imidazole, DMF, rt, 3 d, 70%).
€
817–840; (f) Grassberger, M.; Meingassner, J.; Stutz, A.;
Rappersberger, K.; Wolff, K. Ascomycins. In Psoriasis;
Roenigk, H. H., Maibach, H. I., Eds.; 3rd ed.; Marcel
Dekker: New York, Basel, Hong Kong, 1998; pp 769–779,
Chapter 66; (g) Rappersberger, K.; Komar, M.; Ebelin,
M. E.; Scott, G.; Burtin, P.; Greig, G.; Kehren, J.;
Chibout, S. D.; Holter, W.; Richter, L.; Oberbauer, R.;
€
Cordier, A.; Stutz, A.; Wolff, K. J. Invest. Dermatol. 2002,
119, 876–888; (h) Kapp, A.; Papp, K.; Bingham, A.;
€
Folster-Holst, R.; Ortonne, J. P.; Potter, P.; Gulliver, W.;
Paul, C.; Molloy, S.; Barbier, N.; Hultsch, T.; de Prost, Y.
Irradiation of 14 in MeOH for 8 h, followed by chro-
matography, afforded 15 (69%), which after oxidation
with Cu(II) acetate gave the 6-methoxy derivative 16
(92%), which is ready for the photochemical amide
cleavage. Indeed, irradiation of 16 in MeOH for 6 h
followed by chromatography led to the amide cleavage
product 17 (44%). This establishes a crucial reaction in
the context of the semi-synthetic strategy.
J. Allergy Clin. Immunol. 2002, 110, 277–284; (i) Meurer,
€
€
M.; Folster-Holst, R.; Wozel, G.; Weidinger, G.; Junger,
M.; Brautigam, M. Dermatology 2002, 205, 271–277; (j)
€
In summary, we have shown that (6S)-methoxyasco-
mycin and several of its protected derivatives undergo a
novel amide cleavage reaction upon irradiation in useful
yields. The selective cleavage of an amide bond in an
unprotected multifunctional molecule such as ascomycin
is a remarkable finding. The applicability of this reaction
for developing a semi-synthetic strategy leading to
analogues of 1 modified in the amino acid region will
be further explored.
Wahn, U.; Bos, J. D.; Goodfield, M.; Caputo, R.; Papp,
K.; Manjra, A.; Dobozy, A.; Paul, C.; Molloy, S.;
Graeber, M.; Cherill, R.; DeProst, Y. Pediatrics 2002,
110, e2; (k) Ho, V.; Gupta, A.; Kaufmann, R.; Todd, G.;
€
Vanachlocha, F.; Takaoka, R.; Folster-Holst, R.; Potter,
P.; Marshall, K.; Thurston, M.; Bush, C.; Cherill, R.
J. Pediatr. 2003, 142, 155–162.
3. VanDuyne, G. D.; Standaert, R. F.; Karplus, P. A.;
Schreiber, S. L.; Clardy, J. Science 1991, 252, 839–842.
4. (a) Askin, D.; Reamer, R. A.; Joe, D.; Volante, R. P.;
Shinkai, I. J. Org. Chem. 1990, 55, 5448–5450; (b) Askin,
D.; Joe, D.; Reamer, R. A.; Volante, R. P.; Shinkai, I.
J. Org. Chem. 1990, 55, 5451–5454.
5. (a) Bulusu, A. R. C. M.; Haidl, E. H.; Schulz, G.;
Waldstaetten, P.; Grassberger, M. Indian J. Chem. 1999,
38B, 1159–1164; (b) Bulusu, A. EP 0626385A; Sandoz
Acknowledgements
T.T. thanks the Leonardo da Vinci Program for a fel-
lowship.
€
Ltd, 1994 (c) Bulusu, A. R. C. M.; Waldstatten, P.; Schulz,
G.; Grassberger, M. Tetrahedron Lett. 2004, 45, 2523.
6. (a) Chesta, C. A.; Whitten, D. G. J. Am. Chem. Soc. 1992,
114, 2188–2197; (b) Aoyama, H.; Hasegawa, T.; Watabe,
M.; Shiraishi, H.; Omote, Y. J. Org. Chem. 1978, 43, 419–
422; (c) Aoyama, H.; Sakamoto, M.; Kuwabara, K.;
Yoshida, K.; Omote, Y. J. Am. Chem. Soc. 1983, 105,
1958–1964; (d) Aoyama, H.; Hasegawa, T.; Omote, Y.
J. Am. Chem. Soc. 1979, 101, 5343–5347.
7. All compounds were fully characterised using 1H NMR
(250, 400 or 500 MHz), 13C NMR (100 or 125 MHz) and
mass spectral data and elemental analysis. The 1H and
13C-signal assignments for representative compounds were
made through C–H correlation spectra and 1H-decoupling
experiments.
References and notes
1. (a) Arai, T.; Koyoma, Y.; Suenaga, T.; Honda, H.
J. Antibiot. Ser. A 1962, 15, 231–232; (b) Hatanaka, H.;
Iwami, M.; Kino, T.; Goto, T.; Okuhara, M. J. Antibiot.
1988, 41, 1586–1591; (c) Hatanaka, H.; Kino, T.; Miyata,
S.; Inamura, N.; Kuroda, A.; Goto, T.; Tanaka, H.;
Okuhara, M. J. Antibiot. 1988, 41, 1592–1601; (d) Mor-
isaki, M.; Arai, T. J. Antibiot. 1992, 45, 126–128.
2. (a) Meingassner, J.; Grassberger, M.; Fahrngruber, H.;
€
Moore, H. D.; Schuurman, H.; Stutz, A. Br. J. Dermatol.
1997, 137, 568–576; (b) Grassberger, M.; Baumruker, T.;
Enz, A.; Hiestand, P.; Hultsch, T.; Kalthoff, F.; Schuler,
W.; Schulz, M.; Werner, F.-J.; Winiski, A.; Wolff, B.;
8. Horvath, A. Ph.D. Thesis, University of Vienna, 1993.
9. Guibe, F.; Saint MÕLeux, Y. Tetrahedron Lett. 1981, 22,
3591–3594.
€
Zenke, G. Br. J. Dermatol. 1999, 141, 264–273; (c) Stutz,
A.; Grassberger, M.; Meingassner, J. G. Semin. Cutaneous
10. Olah, G. A.; Narang, S. C.; Gupta, B. G. B.; Malhotra, R.
J. Org. Chem. 1979, 44, 1247–1251.